cesar luiz boguszewski

About cesar luiz boguszewski

cesar luiz boguszewski, With an exceptional h-index of 38 and a recent h-index of 26 (since 2020), a distinguished researcher at Universidade Federal do Paraná, specializes in the field of Doenças Hipofisárias, Neuroendocrinologia, Obesidade, Metabolismo Ósseo, Tireóide.

His recent articles reflect a diverse array of research interests and contributions to the field:

EndoBridge 2023: highlights and pearls

CHARACTERIZATION OF ACROMEGALY ACCORDING TO TUMOR SIZE AT DIAGNOSIS

THU126 SARS-CoV-2 Infection And Vaccination In Patients With Pituitary Diseases: A Pilot Study

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis

OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term …

THU078 The Definition And Epidemiology Of Giant Pituitary GH-Secreting Adenomas Based On Clinical, Imaging, And Hormonal Parameters: A Pilot Study

Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk

2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

cesar luiz boguszewski Information

University

Position

Professor Associado de Endocrinologia e Metabologia

Citations(all)

5292

Citations(since 2020)

3072

Cited By

3199

hIndex(all)

38

hIndex(since 2020)

26

i10Index(all)

98

i10Index(since 2020)

67

Email

University Profile Page

Google Scholar

cesar luiz boguszewski Skills & Research Interests

Doenças Hipofisárias

Neuroendocrinologia

Obesidade

Metabolismo Ósseo

Tireóide

Top articles of cesar luiz boguszewski

CHARACTERIZATION OF ACROMEGALY ACCORDING TO TUMOR SIZE AT DIAGNOSIS

medRxiv

2024

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

THU126 SARS-CoV-2 Infection And Vaccination In Patients With Pituitary Diseases: A Pilot Study

Journal of the Endocrine Society

2023/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis

2023/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

OR01-01 Oral, Once-daily, Paltusotine (Non-peptide Selective Somatostatin Receptor Subtype 2 Agonist) Therapy In Patients With Acromegaly Is Associated With Long-term …

Journal of the Endocrine Society

2023/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

THU078 The Definition And Epidemiology Of Giant Pituitary GH-Secreting Adenomas Based On Clinical, Imaging, And Hormonal Parameters: A Pilot Study

Journal of the Endocrine Society

2023/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

Safety of long-term use of daily and long-acting growth hormone in growth hormone-deficient adults on cancer risk

2023/8/24

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

2023 UPDATE: Luso-Brazilian evidence-based guideline for the management of antidiabetic therapy in type 2 diabetes

2023/7/19

Potential Effects of Oral Isotretinoin on Growth Plate and Height

2023/4/7

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

The science behind the relations among cancer, height, growth patterns, and growth hormone axis

2023/4/1

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

Evaluating home injection compared with healthcare-setting injection of somatostatin analogs: a systematic literature review

2023/3

Bone quality, mineral density, and fractures in heart failure

Plos one

2023/11/3

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing’s disease

Frontiers in Endocrinology

2023/10/9

The new obesity classification based on weight history is not proposed as a guideline

Archives of Endocrinology and Metabolism

2022/11/28

Long-term efficacy and safety of oral, once-daily paltusotine treatment in acromegaly: Two-year interim results from the ACROBAT Advance study

Endocrine Abstracts

2022/10/27

Growth hormone (GH) deficiency and GH replacement therapy in patients previously treated for Cushing’s disease

2022/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

Prevalence of sarcopenia in women at stable weight phase after Roux-en-Y gastric bypass

Archives of Endocrinology and Metabolism

2022/6/10

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

2022/6

Acromegaly and pregnancy: a systematic review and meta-analysis

2022/6

Fernanda Bolfi
Fernanda Bolfi

H-Index: 7

Cesar Luiz Boguszewski
Cesar Luiz Boguszewski

H-Index: 21

ACROBAT advance: once daily, oral paltusotine treatment maintained long-term igf-1 at levels previously achieved with injectable long-acting somatostatin receptor ligands (LA-SRLs)

Endocrine Abstracts

2022/5/7

See List of Professors in cesar luiz boguszewski University(Universidade Federal do Paraná)

Co-Authors

academic-engine